DTC(消費者直接)遺伝子検査の世界市場2019-2023

◆英語タイトル:Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023
◆商品コード:IRTNTR31918
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年8月28日
◆ページ数:123
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア太平洋、ヨーロッパ、北米、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Technavio社の本調査レポートでは、DTC(消費者直接)遺伝子検査の世界市場について調べ、DTC(消費者直接)遺伝子検査の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、DTC(消費者直接)遺伝子検査の市場規模をセグメンテーション別(流通チャンネル別(直販、小売)、サービス別、)と地域別(グローバル、アジア太平洋、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社はDTC(消費者直接)遺伝子検査の世界市場規模が2019-2023期間中に年平均16%成長すると予測しています。
・サマリー
・レポートの範囲
・DTC(消費者直接)遺伝子検査の市場状況
・DTC(消費者直接)遺伝子検査の市場規模
・DTC(消費者直接)遺伝子検査の市場予測
・DTC(消費者直接)遺伝子検査の世界環境:ファイブフォース分析
・市場セグメンテーション:流通チャンネル別(直販、小売)
・市場セグメンテーション:サービス別
・DTC(消費者直接)遺伝子検査の顧客状況
・主要地域別市場規模:グローバル、アジア太平洋、ヨーロッパ、北米、その他
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Direct-to-consumer Genetic Testing Market: About this market
Technavio’s direct-to-consumer genetic testing market analysis considers sales from both direct sales and retail sales. Our analysis also considers the sales of direct-to-consumer genetic testing in Asia, Europe, North America, and ROW. In 2018, the direct sales segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as a reduction in additional costs involved in distribution and logistics will play a significant role in the direct sales segment to maintain its market position. Also, our global direct-to-consumer genetic testing market report looks at factors such as growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits. However, doubts over-analytical and clinical validity, limited reimbursement policies, and concerns over safety and privacy of personal data may hamper the growth of the direct-to-consumer genetic testing industry over the forecast period.

Global Direct-to-consumer Genetic Testing Market: Overview

Growing adoption of direct-to-consumer genetic testing in early disease diagnosis
The adoption of direct-to-consumer genetic testing has increased, especially among people with a family history of certain diseases with a greater chance of their genetic transmission to their progeny. The increasing number of people with Alzheimer, cancer, and Parkinson’s disease has fueled the demand for these tests. Direct-to-consumer genetic testing kit helps in the early diagnosis of diseases and help approach physicians for further monitoring and prevention. This will lead to the expansion of the global direct-to-consumer genetic testing market at a CAGR of over 16% during the forecast period.

Growing adoption of online service platforms
The increase in the adoption of digital trends in the healthcare industry has enabled vendors to have the edge over their competitors by offering better healthcare services. Online ordering facilities has increased the propensity of the consumers to avail more direct-to-consumer genetic tests. This leads the companies to provide attractive discounts to promote sales through online platforms. The availability of a digital database of consumers helps companies to analyze the performance of their products and improve through constant development and upgrades. This adoption of online service platforms is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global direct-to-consumer genetic testing market during the forecast period 2019-2023, click here.

Competitive Landscape
With the presence of several major players, the global direct-to-consumer genetic testing market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct-to-consumer genetic testing manufacturers, that include 23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., Quest Diagnostics Inc.

Also, the direct-to-consumer genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
• Market segmentation by distribution channel
• Comparison by distribution channel
• Direct sales – Market size and forecast 2018-2023
• Retail sales – Market size and forecast 2018-2023
• Market opportunity by distribution channel
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY SERVICE
• Market segmentation by service
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Advances in next-generation genetic sequencing
• Reduction in the cost of services
• Growing adoption of online service platforms
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• 23andMe Inc.
• Invitae Corp.
• Laboratory Corp. of America Holdings
• Myriad Genetics Inc.
• Quest Diagnostics Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO

Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Distribution channel – Market share 2018-2023 (%)
Exhibit 19: Comparison by distribution channel
Exhibit 20: Direct sales – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Direct sales – Year-over-year growth 2019-2023 (%)
Exhibit 22: Retail sales – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Retail sales – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by distribution channel
Exhibit 25: Customer landscape
Exhibit 26: Global direct-to-consumer genetic testing market: Segmentation by service 2018 (%)
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: andMe Inc. – Vendor overview
Exhibit 46: andMe Inc. – Business segments
Exhibit 47: andMe Inc. – Organizational developments
Exhibit 48: andMe Inc. – Key offerings
Exhibit 49: Invitae Corp. – Vendor overview
Exhibit 50: Invitae Corp. – Business segments
Exhibit 51: Invitae Corp. – Organizational developments
Exhibit 52: Invitae Corp. – Geographic focus
Exhibit 53: Invitae Corp. – Key offerings
Exhibit 54: Laboratory Corp. of America Holdings – Vendor overview
Exhibit 55: Laboratory Corp. of America Holdings – Business segments
Exhibit 56: Laboratory Corp. of America Holdings – Organizational developments
Exhibit 57: Laboratory Corp. of America Holdings – Geographic focus
Exhibit 58: Laboratory Corp. of America Holdings – Segment focus
Exhibit 59: Laboratory Corp. of America Holdings – Key offerings
Exhibit 60: Myriad Genetics Inc. – Vendor overview
Exhibit 61: Myriad Genetics Inc. – Business segments
Exhibit 62: Myriad Genetics Inc. – Organizational developments
Exhibit 63: Myriad Genetics Inc. – Segment focus
Exhibit 64: Myriad Genetics Inc. – Key offerings
Exhibit 65: Quest Diagnostics Inc. – Vendor overview
Exhibit 66: Quest Diagnostics Inc. – Business segments
Exhibit 67: Quest Diagnostics Inc. – Organizational developments
Exhibit 68: Quest Diagnostics Inc. – Geographic focus
Exhibit 69: Quest Diagnostics Inc. – Segment focus
Exhibit 70: Quest Diagnostics Inc. – Key offerings
Exhibit 71: Validation techniques employed for market sizing
Exhibit 72: Definition of market positioning of vendors



【掲載企業】

23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., and Quest Diagnostics Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[DTC(消費者直接)遺伝子検査の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆